Fig. 3From: Potential benefits of oral administration of AMORPHOPHALLUS KONJAC glycosylceramides on skin health – a randomized clinical studyEffect of SkinCera on dermatological diagnosis score. a Mean diagnosis score at baseline, 3 weeks and 6 weeks after SkinCera intake (b) Change in mean score from baseline to end of study. Values are expressed as mean ± SD. The data were analyzed by one-way ANOVA followed by Dunnet’s t test. ***p < 0.001 compared to placebo. ns, not significantBack to article page